Walpar Nutritions Limited (NSE:WALPAR)

India flag India · Delayed Price · Currency is INR
47.85
+1.95 (4.25%)
At close: Dec 23, 2025
-1.24%
Market Cap449.33M
Revenue (ttm)757.46M
Net Income (ttm)23.31M
Shares Out9.39M
EPS (ttm)2.49
PE Ratio19.25
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,000
Average Volume5,300
Open47.85
Previous Close45.90
Day's Range47.85 - 47.85
52-Week Range37.70 - 53.30
Beta-0.49
RSI59.21
Earnings DateFeb 12, 2026

About Walpar Nutritions

Walpar Nutritions Limited manufactures and trades pharmaceutical, nutraceutical, herbal, and ayurvedic commodities in India. The company offers G-Flora, a probiotic blend for gut health and immunity; Inosia-F, an inositol supplement; Inovam Plus, a multivitamin; Ironica-CR, controlled-release iron supplement; Myobest, muscle support formula; Ovality, ovarian health support; Ovanyx-F, a female reproductive health supplement; Ovacon-F, women's fertility support; PCOS Care Forte, a PCOS support; Procive-F, female fertility enhancement supplement; ... [Read more]

Industry Pharmaceutical Preparations
Founded 2009
Country India
Stock Exchange National Stock Exchange of India
Ticker Symbol WALPAR
Full Company Profile

Financial Performance

In 2024, Walpar Nutritions's revenue was 719.60 million, an increase of 14.93% compared to the previous year's 626.13 million. Earnings were 23.24 million, an increase of 46.92%.

Financial Statements